GWAS |
- Anorexia nervosa ( 21079607)
- anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028)
- Asthma ( 29273806)
- Atrial fibrillation ( 30061737 29892015)
- Bipolar disorder ( 31043756)
- Body mass index ( 28892062 25673413 29273807 28448500)
- Body mass index (joint analysis main effects and physical activity interaction) ( 28448500)
- Body mass index in physically active individuals ( 28448500)
- Coffee consumption ( 31046077)
- Cognitive ability, years of educational attainment or schizophrenia (pleiotropy) ( 31374203)
- Cognitive function ( 25644384)
- Creatine kinase levels ( 29403010)
- Diisocyanate-induced asthma ( 25918132)
- Economic and political preferences (environmentalism) ( 22566634)
- Fasting blood insulin (BMI interaction) ( 22581228)
- General cognitive ability ( 29844566)
- Glioma ( 28346443)
- Intelligence (MTAG) ( 29326435)
- Night sleep phenotypes ( 27126917)
- Non-glioblastoma glioma ( 28346443)
- Photic sneeze reflex ( 27182965)
- Schizophrenia ( 28991256 30285260)
- Spherical equivalent or myopia (age of diagnosis) ( 29808027)
- Type 2 diabetes ( 30297969)
|
- Alzheimer's disease ( 19118814)
- Amyotrophic lateral sclerosis ( 19451621)
- Amyotrophic lateral sclerosis (sporadic) ( 24529757)
- Arterial stiffness index ( 31235810)
- Chronic periodontitis (mean interproximal clinical attachment level) ( 27601451)
- Metabolite levels ( 23823483)
- Neuranatomic and neurocognitive phenotypes ( 21483430)
- Pelvic organ prolapse (moderate/severe) ( 26545240)
- Response to antidepressants (symptom improvement) ( 29160301)
- Response to antineoplastic agents ( 21659360)
- Response to statin therapy ( 20339536)
- Waist circumference ( 28552196)
|